differences

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:16 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Source Node:
Time Stamp: September 20, 2023 8:36 AM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:16 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

CoinDesk’s Consensus 2023 Draws 15,000 Attendees from Around the Globe to Austin, Texas

Source Node:
Time Stamp: May 10, 2023 12:35 PM - Modified On: May 10, 2023 - Published By:
Source Cluster:
Republished By Plato

AUSTIN, Texas, May 10, 2023 — CoinDesk's annual event, Consensus 2023, concluded on April 28th, bringing together a diverse group of 15,000 attendees, including developers, investors, policymakers, and major brands, to tackle the most pressing challenges facing crypto and Web3 today. CoinDesk is celebrating its 10th anniversary this year and the 9th year of Consensus. As the world's largest and most influential gathering of the crypto, blockchain, and Web3 communities, Consensus 2023 was a call to action to collaborate, innovate and find solutions to drive the industry forward. “Amid a

The AI Model to Combat Technology Biases in the Near Future

Source Node:
Time Stamp: May 2, 2023 11:42 AM - Modified On: May 3, 2023 - Published By:
Source Cluster:
Republished By Plato

Machines are incessantly getting smarter through the use of NLP, or natural language processing; however, there’s a flipside to that as well, where the convenience of AI-powered models, be they chatbots, virtual assistants, or content creation tools, cannot be ruled out altogether. Why should one feel that way? Well, most of the AI models have a biased approach to problem solving. However, with the help of TruthGPT, the future may offer some light on the capabilities of biased AI models, despite their ability to sow social discontent, promote cultural differences, and create

TruthGPT A Revolutionary Language Model Set to Change the Game

Source Node:
Time Stamp: May 1, 2023 5:43 AM - Modified On: May 2, 2023 - Published By:
Source Cluster:
Republished By Plato

In recent years, natural language processing (NLP) has become a buzzword in the world of technology. With the increasing demand for AI-powered chatbots, virtual assistants, and content creation tools, companies are investing heavily in developing more advanced NLP systems. However, with the help of TruthGPT, the future may offer some light on the capabilities of biased AI models, despite their ability to sow social discontent, promote cultural differences, and create barriers around a more friendly and inviting globalized civic society. The Fate So Far: The Rise of Artificial Intelligence Chatbots

Digital Health and Technology Trends in the USA

Source Node:
Time Stamp: August 1, 2022 6:46 AM - Modified On: August 1, 2022 - Published By:
Source Cluster:
Republished By Plato

What role and purpose will businesses accept to impact the social contract, and how might consumer and provider empowerment might bring change to healthcare business models using technology? The Partners in Digital Health blockchain in healthcare and telehealth portfolio both reflect and set trends in the marketplace. Here are a few trends and current issues to ponder. Cost, place, and preference have prioritized the care at home care and care transitions as aging populations and a looming healthcare worker shortage impact the US health system, where virtual care presents an